BioLineRx Ltd. (BLRX)

Balance Sheet (Annual)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011 - 2010
Cash & Equivalents	57.14	22.59	27.49	30.15	49.48	35.62	47.66	34.68	18.22	22.34	Upgrade
Cash & Cash Equivalents	57.14	22.59	27.49	30.15	49.48	35.62	47.66	34.68	18.22	22.34	Upgrade
Cash Growth	152.96%	-17.83%	-8.83%	-39.07%	38.91%	-25.26%	37.44%	90.36%	-18.46%	-	Upgrade
Receivables	0.14	0.14	0.61	1.34	0.59	0.22	0.29	0.26	0.36	0.63	Upgrade
Other Current Assets	0.13	0.15	0.11	0.49	0.31	0.26	0.23	0.22	0.26	0.23	Upgrade
Total Current Assets	57.4	22.88	28.21	31.98	50.38	36.1	48.18	35.16	18.84	23.2	Upgrade
Property, Plant & Equipment	2.28	2.7	3.47	2.23	2.51	2.61	2.91	0.72	0.71	0.89	Upgrade
Long-Term Investments	0	0	0	0	1	0	0	0	0	0	Upgrade
Goodwill and Intangibles	21.7	21.71	21.89	21.97	7.02	0.18	0.15	0.12	0.25	0.3	Upgrade
Other Long-Term Assets	0	0	0	0.06	0.06	0.05	0.06	0.22	0.21	1.04	Upgrade
Total Long-Term Assets	23.99	24.41	25.36	24.26	10.59	2.84	3.12	1.05	1.18	2.23	Upgrade
Total Assets	81.39	47.29	53.57	56.23	60.97	38.94	51.3	36.21	20.02	25.43	Upgrade
Accounts Payable	5.57	5.92	7.79	4.49	5.52	2.59	1.91	1.65	2.29	3.44	Upgrade
Current Debt	2.93	3.28	2.89	0.9	0.09	0.09	0.09	0	0	0.04	Upgrade
Other Current Liabilities	1.23	1.44	1.28	1.36	1.11	0.98	1.14	1.25	0.76	3.25	Upgrade
Total Current Liabilities	9.72	10.64	11.97	6.75	6.72	3.66	3.14	2.91	3.05	6.72	Upgrade
Long-Term Debt	1.73	4.4	7.56	7.84	0.16	0.25	0.34	0	0	0	Upgrade
Other Long-Term Liabilities	1.86	10.22	0.66	0.32	1.21	0	0.21	1.5	5.24	3.04	Upgrade
Total Long-Term Liabilities	3.59	14.62	8.22	8.16	1.36	0.25	0.55	1.5	5.24	3.04	Upgrade
Total Liabilities	13.3	25.26	20.19	14.91	8.08	3.91	3.69	4.41	8.29	9.77	Upgrade
Total Debt	4.65	7.68	10.46	8.73	0.25	0.34	0.44	0	0	0.04	Upgrade
Debt Growth	-39.47%	-26.50%	19.72%	3393.20%	-27.11%	-21.51%	-	-	-	-67.15%	Upgrade
Common Stock	374.54	301.43	282.76	265.26	253.86	211.65	208.39	178.19	144.19	140.08	Upgrade
Retained Earnings	-305.04	-277.99	-247.97	-222.52	-199.56	-175.21	-159.37	-144.97	-133.89	-124.41	Upgrade
Comprehensive Income	-1.42	-1.42	-1.42	-1.42	-1.42	-1.42	-1.42	-1.42	1.42	0	Upgrade
Shareholders' Equity	68.09	22.03	33.38	41.32	52.88	35.03	47.61	31.81	11.72	15.66	Upgrade
Total Liabilities and Equity	81.39	47.29	53.57	56.23	60.97	38.94	51.3	36.21	20.02	25.43	Upgrade
Net Cash / Debt	52.48	14.9	17.03	21.42	49.23	35.28	47.23	34.68	18.22	22.31	Upgrade
Net Cash / Debt Growth	252.17%	-12.51%	-20.47%	-56.50%	39.55%	-25.30%	36.18%	90.36%	-18.32%	-	Upgrade
Net Cash Per Share	0.08	0.06	0.12	0.20	0.55	0.63	0.92	1.07	0.81	1.32	Upgrade
Working Capital	47.69	12.24	16.24	25.23	43.65	32.44	45.04	32.25	15.78	16.48	Upgrade
Book Value Per Share	1.54	1.31	3.42	5.71	8.82	9.36	13.89	14.71	7.82	13.87	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).